Xibrom ISTA Pharmaceuticals, Inc. - Treatment for Ocular Inflammation Following Cataract Surgery
Xibrom is a sterile, topical, twice-daily, non-steroidal anti-inflammatory (NSAID) solution for the treatment of ocular inflammation following cataract surgery.Posted: March 2005
Related articles
- Xibrom - ISTA Pharmaceuticals, Inc. - New Indication Approved - January 27, 2006
- FDA Accepts ISTA Pharmaceuticals' New Drug Application for Xibrom - July 26, 2004
- ISTA Pharmaceuticals Announces Submission of Xibrom NDA to the FDA - May 25, 2004
Xibrom (bromfenac) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
